I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Oral Akynzeo vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
MyRisk: Efficacy and safety evaluation of oral Akynzeo in patients receiving MEC at high risk of developing CINV based on a prediction tool. A multinational and multicenter study.
- 3 views
- 25 Sep, 2021
- 5 locations
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
This is a multicentre, single-arm, phase II study to investigate the safety and antiemetic efficacy of Akynzeo (a fixed dose combination of palonosetron and netupitant) plus dexamethasone in
antiemetics
emetic
cancer
absolute neutrophil count
palonosetron
- 7 views
- 15 Feb, 2022
- 1 location